Pulse Biosciences, Inc.
PLSE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001625101
In the last 90 days, Pulse Biosciences, Inc. insiders filed 2 open-market purchases and 0 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $297.0M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Pulse Biosciences, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 96 | 2 | 105 | +11 |
| Shares | 7.77M | 12.2K | 10.7M | +2.96M (+38.1%) |
| Value | $167.6M | $264.3K | $297.0M | +$129.6M (+77.5%) |
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Pulse Biosciences, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 106,457 | $2.95M | 0.00% |
| Norges Bank | 105,647 | $2.93M | 0.00% |
| Sectoral Asset Management Inc | 67,895 | $1.88M | 1.31% |
| Mangrove Partners | 30,612 | $848.9K | 0.06% |
| Raymond James Financial Inc | 15,280 | $423.7K | 0.00% |
| Quantinno Capital Management LP | 10,518 | $291.7K | 0.00% |
| Gsa Capital Partners LLP | 10,468 | $290.0K | 0.02% |
| Invesco Ltd. | 10,258 | $284.5K | 0.00% |
| Jupiter Topco LLC | 8,700 | $241.1K | 0.00% |
| AQR Capital Management LLC | 8,566 | $237.5K | 0.00% |
| STRS Ohio | 3,500 | $97.1K | 0.00% |
| US Bancorp | 2,000 | $55.5K | 0.00% |
| Simplex Trading, LLC | 420 | $11.6K | 0.00% |
| Jones Financial Companies LLLP | 100 | $2.85K | 0.00% |
| Global Retirement Partners, LLC | 54 | $1.50K | 0.00% |
| Parallel Advisors, LLC | 50 | $1.39K | 0.00% |
| SJS Investment Consulting Inc. | 32 | $888 | 0.00% |
| Quarry LP | 14 | $388 | 0.00% |
| Essential Partners LLC | 5 | $139 | 0.00% |
| Silver Grove Financial Group, Inc. | 3 | $83 | 0.00% |
| Clearstead Advisors, LLC | 1 | $28 | 0.00% |
Sold out (10)
Institutions that held Pulse Biosciences, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| LMR Partners LLP | 213,137 | $4.60M |
| Parkman Healthcare Partners LLC | 50,125 | $1.08M |
| XTX Topco Ltd | 23,841 | $514.7K |
| Susquehanna International Group, LLP | 13,411 | $289.5K |
| Bender Robert & Associates | 12,190 | $263.2K |
| Brevan Howard Capital Management LP | 12,164 | $262.6K |
| Quantbot Technologies LP | 161 | $3.48K |
| Aster Capital Management (DIFC) Ltd | 105 | $1.69K |
| Fortitude Family Office, LLC | 40 | $864 |
| MAI Capital Management | 7 | $152 |
Not filed for Q2 2026 yet (2)
Institutions that held Pulse Biosciences, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Skopos Labs, Inc. | 10,470 | $226.0K |
| CWM, LLC | 1,770 | $38.2K |